Assessment of health state utilities and quality of life in patients with malignant esophageal dysphagia

Stephan M. Wildi, Monty H. Cox, Leslie L. Clark, Robert Turner, Robert H. Hawes, Brenda J. Hoffman, Michael B. Wallace

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

OBJECTIVES: Palliation of terminal conditions such as malignant dysphagia must take into account individual preferences for aggressive or nonaggressive care, with a focus on quality of life. Despite this, there are very few data on patients' preferences for palliative therapy. This study is designed to quantitatively determine individual preferences for palliation of malignant dysphagia using health state utilities (HSU). METHODS: HSU were measured using three methods: time trade-off (TTO), visual analog scale (VAS), and the EQ-5D. Patients with esophageal cancer were asked to rate their own state of health and of three standardized scenarios of local, regional, and metastatic disease. RESULTS: Fifty patients with esophageal cancer were enrolled. Using the TTO method, the utilities of their own health state were 0.80 (95% CI 0.59-0.99) for localized, 0.54 (0.37-0.70) for regional, and 0.52 (0.32-0.71) for metastatic cancer showing no significant difference in mean utility scores for the three staging groups. VAS and EQ5D gave statistically similar values to TTO. Patients consistently rated their own utility better than the utility of standardized scenarios with similar stage and prognosis. Independent of their staging, patients with high dysphagia scores rated their utility worse than patients with low dysphagia scores. CONCLUSIONS: These results confirm the perceived poor state of health of patients with esophageal cancer and are substantially lower than previous estimates in operated patients. Cost-effectiveness models must take into account significant differences between patients' assessment of their own state of health, and that of a "societal" perspective of others with a similar disease. All three methods provided similar estimates. Given the ease of use of VAS and EQ-5D, these methods may be preferable to TTO.

Original languageEnglish (US)
Pages (from-to)1044-1049
Number of pages6
JournalAmerican Journal of Gastroenterology
Volume99
Issue number6
DOIs
StatePublished - Jun 2004

Fingerprint

Deglutition Disorders
Quality of Life
Health
Esophageal Neoplasms
Visual Analog Scale
Patient Preference
Palliative Care
Cost-Benefit Analysis
Neoplasms

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Wildi, S. M., Cox, M. H., Clark, L. L., Turner, R., Hawes, R. H., Hoffman, B. J., & Wallace, M. B. (2004). Assessment of health state utilities and quality of life in patients with malignant esophageal dysphagia. American Journal of Gastroenterology, 99(6), 1044-1049. https://doi.org/10.1111/j.1572-0241.2004.30166.x

Assessment of health state utilities and quality of life in patients with malignant esophageal dysphagia. / Wildi, Stephan M.; Cox, Monty H.; Clark, Leslie L.; Turner, Robert; Hawes, Robert H.; Hoffman, Brenda J.; Wallace, Michael B.

In: American Journal of Gastroenterology, Vol. 99, No. 6, 06.2004, p. 1044-1049.

Research output: Contribution to journalArticle

Wildi, Stephan M. ; Cox, Monty H. ; Clark, Leslie L. ; Turner, Robert ; Hawes, Robert H. ; Hoffman, Brenda J. ; Wallace, Michael B. / Assessment of health state utilities and quality of life in patients with malignant esophageal dysphagia. In: American Journal of Gastroenterology. 2004 ; Vol. 99, No. 6. pp. 1044-1049.
@article{c8a064c3017c48f881b336c84007b448,
title = "Assessment of health state utilities and quality of life in patients with malignant esophageal dysphagia",
abstract = "OBJECTIVES: Palliation of terminal conditions such as malignant dysphagia must take into account individual preferences for aggressive or nonaggressive care, with a focus on quality of life. Despite this, there are very few data on patients' preferences for palliative therapy. This study is designed to quantitatively determine individual preferences for palliation of malignant dysphagia using health state utilities (HSU). METHODS: HSU were measured using three methods: time trade-off (TTO), visual analog scale (VAS), and the EQ-5D. Patients with esophageal cancer were asked to rate their own state of health and of three standardized scenarios of local, regional, and metastatic disease. RESULTS: Fifty patients with esophageal cancer were enrolled. Using the TTO method, the utilities of their own health state were 0.80 (95{\%} CI 0.59-0.99) for localized, 0.54 (0.37-0.70) for regional, and 0.52 (0.32-0.71) for metastatic cancer showing no significant difference in mean utility scores for the three staging groups. VAS and EQ5D gave statistically similar values to TTO. Patients consistently rated their own utility better than the utility of standardized scenarios with similar stage and prognosis. Independent of their staging, patients with high dysphagia scores rated their utility worse than patients with low dysphagia scores. CONCLUSIONS: These results confirm the perceived poor state of health of patients with esophageal cancer and are substantially lower than previous estimates in operated patients. Cost-effectiveness models must take into account significant differences between patients' assessment of their own state of health, and that of a {"}societal{"} perspective of others with a similar disease. All three methods provided similar estimates. Given the ease of use of VAS and EQ-5D, these methods may be preferable to TTO.",
author = "Wildi, {Stephan M.} and Cox, {Monty H.} and Clark, {Leslie L.} and Robert Turner and Hawes, {Robert H.} and Hoffman, {Brenda J.} and Wallace, {Michael B.}",
year = "2004",
month = "6",
doi = "10.1111/j.1572-0241.2004.30166.x",
language = "English (US)",
volume = "99",
pages = "1044--1049",
journal = "American Journal of Gastroenterology",
issn = "0002-9270",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - Assessment of health state utilities and quality of life in patients with malignant esophageal dysphagia

AU - Wildi, Stephan M.

AU - Cox, Monty H.

AU - Clark, Leslie L.

AU - Turner, Robert

AU - Hawes, Robert H.

AU - Hoffman, Brenda J.

AU - Wallace, Michael B.

PY - 2004/6

Y1 - 2004/6

N2 - OBJECTIVES: Palliation of terminal conditions such as malignant dysphagia must take into account individual preferences for aggressive or nonaggressive care, with a focus on quality of life. Despite this, there are very few data on patients' preferences for palliative therapy. This study is designed to quantitatively determine individual preferences for palliation of malignant dysphagia using health state utilities (HSU). METHODS: HSU were measured using three methods: time trade-off (TTO), visual analog scale (VAS), and the EQ-5D. Patients with esophageal cancer were asked to rate their own state of health and of three standardized scenarios of local, regional, and metastatic disease. RESULTS: Fifty patients with esophageal cancer were enrolled. Using the TTO method, the utilities of their own health state were 0.80 (95% CI 0.59-0.99) for localized, 0.54 (0.37-0.70) for regional, and 0.52 (0.32-0.71) for metastatic cancer showing no significant difference in mean utility scores for the three staging groups. VAS and EQ5D gave statistically similar values to TTO. Patients consistently rated their own utility better than the utility of standardized scenarios with similar stage and prognosis. Independent of their staging, patients with high dysphagia scores rated their utility worse than patients with low dysphagia scores. CONCLUSIONS: These results confirm the perceived poor state of health of patients with esophageal cancer and are substantially lower than previous estimates in operated patients. Cost-effectiveness models must take into account significant differences between patients' assessment of their own state of health, and that of a "societal" perspective of others with a similar disease. All three methods provided similar estimates. Given the ease of use of VAS and EQ-5D, these methods may be preferable to TTO.

AB - OBJECTIVES: Palliation of terminal conditions such as malignant dysphagia must take into account individual preferences for aggressive or nonaggressive care, with a focus on quality of life. Despite this, there are very few data on patients' preferences for palliative therapy. This study is designed to quantitatively determine individual preferences for palliation of malignant dysphagia using health state utilities (HSU). METHODS: HSU were measured using three methods: time trade-off (TTO), visual analog scale (VAS), and the EQ-5D. Patients with esophageal cancer were asked to rate their own state of health and of three standardized scenarios of local, regional, and metastatic disease. RESULTS: Fifty patients with esophageal cancer were enrolled. Using the TTO method, the utilities of their own health state were 0.80 (95% CI 0.59-0.99) for localized, 0.54 (0.37-0.70) for regional, and 0.52 (0.32-0.71) for metastatic cancer showing no significant difference in mean utility scores for the three staging groups. VAS and EQ5D gave statistically similar values to TTO. Patients consistently rated their own utility better than the utility of standardized scenarios with similar stage and prognosis. Independent of their staging, patients with high dysphagia scores rated their utility worse than patients with low dysphagia scores. CONCLUSIONS: These results confirm the perceived poor state of health of patients with esophageal cancer and are substantially lower than previous estimates in operated patients. Cost-effectiveness models must take into account significant differences between patients' assessment of their own state of health, and that of a "societal" perspective of others with a similar disease. All three methods provided similar estimates. Given the ease of use of VAS and EQ-5D, these methods may be preferable to TTO.

UR - http://www.scopus.com/inward/record.url?scp=3142713233&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3142713233&partnerID=8YFLogxK

U2 - 10.1111/j.1572-0241.2004.30166.x

DO - 10.1111/j.1572-0241.2004.30166.x

M3 - Article

C2 - 15180723

AN - SCOPUS:3142713233

VL - 99

SP - 1044

EP - 1049

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

SN - 0002-9270

IS - 6

ER -